Efficacy, immunogenicity and safety of CoronaVac® in children and adolescents aged 6 months to 17 years: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial August 6, 2024
Performance evaluation of microfluidic microplate-based fluorescent ELISA for qualitative detection of SARS-CoV-2–specific IgG and IgM August 6, 2024
Microstructural brain assessment in late-life depression and apathy using diffusion MRI multi-compartments models and tractometry August 6, 2024
Synthesis and preclinical testing of a selective beta-subtype agonist of thyroid hormone receptor ZTA-261 August 6, 2024
Clinical relevance of critical plasma homocysteine levels in predicting rupture risk for small and medium-sized intracranial aneurysms August 6, 2024
Diagnostic utility of DNA methylation analysis in genetically unsolved pediatric epilepsies and CHD2 episignature refinement August 6, 2024
Patient-centric thresholding of Cobas® EGFR mutation Test v2 for surveillance of EGFR-mutated metastatic non-small cell lung cancer August 6, 2024
Comparison of the therapeutic effect of platelet-rich plasma and injectable platelet-rich fibrin on testicular torsion/detorsion injury in rats August 5, 2024
Translucency and colour masking ability of hybrid CAD/CAM materials with different thicknesses: in vitro study August 5, 2024
Link between remnant cholesterol and the reversion to normoglycemia in Chinese adults with prediabetes: a 5-year cohort study August 5, 2024
The acute effects of variations in the flour composition of crackers on the glycemic index and glycemic responses in healthy adults August 5, 2024
Using a simplified Downes score to predict the receipt of surfactant in a highly resourced setting August 5, 2024
Measuring neuroplasticity in human development: the potential to inform the type and timing of mental health interventions August 5, 2024
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis August 5, 2024
Average steps per day as marker of treatment response with anti-CGRP mAbs in adults with chronic migraine: a pilot study August 5, 2024